Goldman Sachs downgraded Eli Lilly (NYSE: LLY) from Neutral to Sell with a price target of $48.00 (from $52.00). Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE